Natco Furthers Chinese Interest With Xinjiang Pharmaceutical Alliance
Indian Firm ‘Active In China, But Through Partnerships,’ First Approval In 2022
With a strategy to expand its reach across Asian markets, Natco Pharma has struck a distribution agreement with Zhongchao Inc.’s Xinjiang Pharmaceutical to sell select products in China.
